Skin of Color Update 30% Off Registration, Use Code: JDD30
Skip to main content
Atopic DermatitisFeatured PodcastPodcast Highlights

Perspectives on Managing Moderate-to-Severe Atopic Dermatitis

By March 30, 2021March 18th, 2026No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Perspectives on Managing Moderate-to-Severe Atopic Dermatitis

Drs. April Armstrong, Lawrence Eichenfield & Adam Friedman

 

The Ps of Lichen Planus got nothing on this alliteration filled podcast that was purposefully positioned to perfect your practice prowess to punish the pruritus and picking of AD. Join host Dr. Adam Friedman in part four of five of this Atopic Dermatitis dedicated series as he parties with and picks the brains of dermatology powerhouses Dr.s April Armstrong and Lawrence Eichenfield on pursuing a practical and powerful process to partner with patients of all ages and partake in a long standing management strategy. Please do not push this one off – I promise it is educational perfection. (That’s 24 Ps!)
Listen Now
Learning Objectives
Upon completion of this podcast participants should be able to:

  • Discuss management strategies for patients with moderate-to-severe atopic dermatitis
  • Identify common co-morbidities of atopic dermatitis and strategies for optimal patient care
This podcast is supported by an independent medical education grant provided by Sanofi Genzyme & Regeneron Pharmaceuticals.
Disclosures

April W. Armstrong, MD, MPH – No disclosures.

Lawrence F. Eichenfield, MD – Grant/Research Support: Abbvie, Pfizer, Regeneron, Sanofi-Genzyme, Ortho Derm, Verrica. Consultant: Almirall, Arcutis, Asana, Dermavant, Dermira, Forte, Galderma, Incyte, Leo Pharma, Lilly, Novartis, OrthoDerm. Speakers’ Bureau: Pfizer, Regeneron, Sanofi-Genzyme.

Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speakers’ Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.

You May Also Like

APP-solutely Essential: Putting Corticosteroid Stewardship Into Practice

| Featured Articles, Featured Podcast, Global Steroidal Stewardship, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Douglas DiRuggiero  Corticosteroids remain one of dermatology’s most reliable workhorses, but good stewardship isn’t about putting the horse out to pasture. It’s about knowing when to ride, when to…

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

| Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…

F around and Find Out: Failing Forward, IL-17F in Focus, and Finding New Treatment Paradigms and Friendships through Industry Collaborations

| Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Dr. Tae Oh For too long, the therapeutic ladder in hidradenitis suppurativa has often looked less like a ladder and more like an uneven mound: try this, fail that,…

Leave a Reply